- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07662733
Effectiveness of Perioperative Percutaneous Acupuncture on Postoperative Sleep Disturbances and Chronic Pain in Patients Undergoing Video-Assisted Thoracoscopic Lung Cancer Resection: A Prospective, Randomized, Single-Blind, Superiority Controlled Trial (PASA-VATS)
17. juni 2026 oppdatert av: LIna Huang, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Effectiveness of Perioperative Percutaneous Acupoint Acupuncture on Postoperative Sleep Disturbances in Patients Undergoing Video-Assisted Thoracoscopic Lung Cancer Resection: A Prospective, Randomized, Single-Blind, Superiority Controlled Trial
This study evaluates whether acupuncture at specific body points before and after surgery can improve sleep quality and reduce long-term postoperative pain in patients undergoing video-assisted thoracoscopic lung cancer resection.
Eligible adult patients will be randomly assigned to receive either true acupuncture or sham (placebo) acupuncture in addition to standard care.
Chronic pain will be assessed during hospital stay and up to 6 months after surgery.
Studieoversikt
Status
Rekruttering
Intervensjon / Behandling
Studietype
Intervensjonell
Registrering (Antatt)
316
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
-
Shanghai, Kina
- Rekruttering
- Shanghai First People's Hospital
-
Ta kontakt med:
- Na li Huang, PhD
- Telefonnummer: +86-18001780050
- E-post: Honilla@163.com
-
-
Shanghai Municipality
-
Shanghai, Shanghai Municipality, Kina, 201620
- Rekruttering
- Shanghai First People's Hospital
-
Ta kontakt med:
- Na li Huang, PhD
- Telefonnummer: +86-18001780050
- E-post: Honilla@163.com
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
- Eldre voksen
Tar imot friske frivillige
Nei
Beskrivelse
Inclusion Criteria:
- Patients aged 18-75 years scheduled for elective video-assisted thoracoscopic surgery (VATS) for lung cancer resection.
- American Society of Anesthesiologists (ASA) physical status classification I-II.
- Body Mass Index (BMI) between 18.5 and 28 kg/m².
- Clinical tumor stage according to the 8th edition of the AJCC/UICC TNM Classification: cTis-3N0-1M0.
- Mentally competent, able to understand and correctly use the Numeric Rating Scale (NRS) for pain assessment.
- Willing and able to provide written informed consent prior to study participation.
Exclusion Criteria:
- Critical preoperative condition or inability to cooperate.
- History of sleep apnea or moderate to severe snoring.
- Pittsburgh Sleep Quality Index (PSQI) ≥7 or Athens Insomnia Scale (AIS) score ≥6.
- Implanted cardiac pacemaker, preoperative sinus bradycardia (heart rate ≤50 bpm), sinoatrial node disease, or second-/third-degree atrioventricular block.
- Long-term use of anticonvulsants, antidepressants, or other psychotropic medications.
- Known hypersensitivity or allergy to the study materials (needles/devices) or related medications.
- Severe cardiac, hepatic, or renal dysfunction.
- Participation in another clinical trial within the past 3 months.
- Hearing and/or language communication impairment.
- Pregnancy or breastfeeding.
- Fever (body temperature ≥38.5°C) or clinical evidence of infection (hematological, radiological, and/or microbiological) prior to surgery.
- Planned reoperation, or anticipated postoperative recurrence, severe complications, or critical illness requiring exclusion from follow-up.
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Dobbelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Acupuncture Group
Manual acupuncture at HT7, PC6, ST36, KI6 bilaterally before and after surgery; needles retained 30 min with deqi sensation.
|
Participants in the acupuncture group will receive manual acupuncture at four bilateral acupoints: Heart 7 (HT7 Shenmen), Pericardium 6 (PC6 Neiguan), Stomach 36 (ST36 Zusanli), and Kidney 6 (KI6 Zhaohai).
Acupuncture will be performed on the night before surgery, on the night of the day of surgery, and on the first postoperative night (total of 3 sessions).
Sterile disposable stainless steel needles (0.25 mm × 40 mm) will be inserted to a depth of 15-25 mm depending on location, with gentle lifting-thrusting and twisting until "Deqi" sensation (aching, heaviness, or tingling) is obtained.
Needles will be retained for 30 minutes, during which manual stimulation will be applied every 10 minutes.
No electrical stimulation will be used.
Standard perioperative care will be provided to all participants.
|
|
Placebo komparator: Sham Acupuncture Group
Non-penetrating placebo needle applied at same acupoints (HT7, PC6, ST36, KI6) with identical procedure and duration; no skin penetration or deqi.
|
Participants in the sham acupuncture group will undergo a placebo procedure using non-penetrating sham needles (e.g., Streitberger or similar non-skin-piercing placebo needle) applied at the same acupoints (bilateral HT7, PC6, ST36, KI6) and on the same schedule (the night before surgery, the night of surgery day, and postoperative day 1; total of 3 sessions).
The sham needle tip retracts into the base upon contact with the skin, producing a tactile sensation without skin penetration or Deqi.
The device will be left in place for 30 minutes without manipulation, mimicking the true acupuncture procedure in appearance and duration.
Standard perioperative care will be provided to all participants.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Incidence of Postoperative Sleep Disturbance as Assessed by the Athens Insomnia Scale (AIS)
Tidsramme: Postoperative days 1, 2, and at hospital discharge (day 3-5)
|
AIS is an 8-item self-report scale.
A total score ≥6 indicates clinically significant insomnia/sleep disturbance.
Higher scores indicate worse sleep quality.
|
Postoperative days 1, 2, and at hospital discharge (day 3-5)
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
13. juni 2025
Primær fullføring (Antatt)
28. februar 2027
Studiet fullført (Antatt)
29. november 2027
Datoer for studieregistrering
Først innsendt
17. juni 2026
Først innsendt som oppfylte QC-kriteriene
17. juni 2026
Først lagt ut (Faktiske)
23. juni 2026
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
23. juni 2026
Siste oppdatering sendt inn som oppfylte QC-kriteriene
17. juni 2026
Sist bekreftet
1. juni 2026
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- [2026]No.319
- Yuan Lun Kuai 【2026】No.319 (Annen identifikator: Ethics Committee of Shanghai First People's Hospital)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
NEI
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .